APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Basal Insulin (Long-Acting Insulin)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Basal Insulin (Long-Acting Insulin) Market Outlook and Growth Opportunities 2026

Report ID 173969290420 December 2025193 pages

Choose your research edition.

Industry ResearchBasal Insulin (Long-Acting Insulin) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Basal Insulin (Long-Acting Insulin) Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Basal Insulin (Long-Acting Insulin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Basal Insulin (Long-Acting Insulin) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Basal Insulin (Long-Acting Insulin) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Basal Insulin (Long-Acting Insulin) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Basal Insulin (Long-Acting Insulin) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Basal Insulin (Long-Acting Insulin) market include Wockhardt, Eli Lilly, Julphar, Sedico, Sanofi Aventis, Novo Nordisk, Exir and Biocon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Basal Insulin (Long-Acting Insulin) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Basal Insulin (Long-Acting Insulin) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Basal Insulin (Long-Acting Insulin) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Basal Insulin (Long-Acting Insulin) market size, projected growth trends, production technologies, key applications, and end-use industries.

Basal Insulin (Long-Acting Insulin) Segment by Company

Wockhardt

Eli Lilly

Julphar

Sedico

Sanofi Aventis

Novo Nordisk

Exir

Biocon

Basal Insulin (Long-Acting Insulin) Segment by Type

Basaglar

Lantus

Levemir

Biosimilar Glargines

Toujeo

Tresiba

Basal Insulin (Long-Acting Insulin) Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Basal Insulin (Long-Acting Insulin) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Basal Insulin (Long-Acting Insulin) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Basal Insulin (Long-Acting Insulin) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Basal Insulin (Long-Acting Insulin) significant trends, drivers, influence factors in global and regions.

6. To analyze Basal Insulin (Long-Acting Insulin) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Basal Insulin (Long-Acting Insulin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Basal Insulin (Long-Acting Insulin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Basal Insulin (Long-Acting Insulin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Basal Insulin (Long-Acting Insulin) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Basal Insulin (Long-Acting Insulin) industry.

Chapter 3: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Basal Insulin (Long-Acting Insulin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Basal Insulin (Long-Acting Insulin) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Basal Insulin (Long-Acting Insulin) Industry Trends Table 2. Basal Insulin (Long-Acting Insulin) Industry Drivers Table 3. Basal Insulin (Long-Acting Insulin) Industry Opportunities and Challenges Table 4. Basal Insulin (Long-Acting Insulin) Industry Restraints Table 5. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Company (2021-2026) Table 7. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Company (2021-2026) Table 9. Global Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Basal Insulin (Long-Acting Insulin) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Basal Insulin (Long-Acting Insulin) Key Company Manufacturing Base & Headquarters Table 12. Global Basal Insulin (Long-Acting Insulin) Company, Product Type & Application Table 13. Global Basal Insulin (Long-Acting Insulin) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Basaglar Table 18. Significant Companies of Lantus Table 19. Significant Companies of Levemir Table 20. Significant Companies of Biosimilar Glargines Table 21. Significant Companies of Toujeo Table 22. Significant Companies of Tresiba Table 23. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Type (2021-2026) Table 27. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Type (2027-2032) Table 28. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Type (2021-2026) Table 32. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Type 1 Diabetes Table 34. Significant Companies of Type 2 Diabetes Table 35. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2021-2026) Table 39. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2027-2032) Table 40. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Application (2021-2026) Table 44. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Application (2027-2032) Table 45. Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2026) & (K Units) Table 47. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2021-2026) Table 48. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2027-2032) & (K Units) Table 49. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2027-2032) Table 50. Global Basal Insulin (Long-Acting Insulin) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Region (2021-2026) Table 53. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Region (2027-2032) Table 55. Global Basal Insulin (Long-Acting Insulin) Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Basal Insulin (Long-Acting Insulin) Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Basal Insulin (Long-Acting Insulin) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Basal Insulin (Long-Acting Insulin) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 60. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2021-2026) Table 61. Global Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 62. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2027-2032) Table 63. Global Basal Insulin (Long-Acting Insulin) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Basal Insulin (Long-Acting Insulin) Sales Value Market Share by Country (2021-2026) Table 65. Global Basal Insulin (Long-Acting Insulin) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Basal Insulin (Long-Acting Insulin) Sales Value Market Share by Country (2027-2032) Table 67. Wockhardt Company Information Table 68. Wockhardt Business Overview Table 69. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio Table 71. Wockhardt Recent Development Table 72. Eli Lilly Company Information Table 73. Eli Lilly Business Overview Table 74. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio Table 76. Eli Lilly Recent Development Table 77. Julphar Company Information Table 78. Julphar Business Overview Table 79. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio Table 81. Julphar Recent Development Table 82. Sedico Company Information Table 83. Sedico Business Overview Table 84. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio Table 86. Sedico Recent Development Table 87. Sanofi Aventis Company Information Table 88. Sanofi Aventis Business Overview Table 89. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio Table 91. Sanofi Aventis Recent Development Table 92. Novo Nordisk Company Information Table 93. Novo Nordisk Business Overview Table 94. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio Table 96. Novo Nordisk Recent Development Table 97. Exir Company Information Table 98. Exir Business Overview Table 99. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Exir Basal Insulin (Long-Acting Insulin) Product Portfolio Table 101. Exir Recent Development Table 102. Biocon Company Information Table 103. Biocon Business Overview Table 104. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio Table 106. Biocon Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Basal Insulin (Long-Acting Insulin) Distributors List Table 110. Basal Insulin (Long-Acting Insulin) Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Basal Insulin (Long-Acting Insulin) Product Image Figure 2. Global Basal Insulin (Long-Acting Insulin) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Basal Insulin (Long-Acting Insulin) Sales (2021-2032) & (K Units) Figure 5. Global Basal Insulin (Long-Acting Insulin) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Basal Insulin (Long-Acting Insulin) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Basaglar Image Figure 10. Lantus Image Figure 11. Levemir Image Figure 12. Biosimilar Glargines Image Figure 13. Toujeo Image Figure 14. Tresiba Image Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Type (2021-2032) Figure 18. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Basal Insulin (Long-Acting Insulin) Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Type (2021-2032) Figure 21. Type 1 Diabetes Image Figure 22. Type 2 Diabetes Image Figure 23. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2021-2032) Figure 26. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Basal Insulin (Long-Acting Insulin) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Application (2021-2032) Figure 29. Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Basal Insulin (Long-Acting Insulin) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Basal Insulin (Long-Acting Insulin) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Basal Insulin (Long-Acting Insulin) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Basal Insulin (Long-Acting Insulin) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Basal Insulin (Long-Acting Insulin) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Basal Insulin (Long-Acting Insulin) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Basaglar
  • Lantus
  • Levemir
  • Biosimilar Glargines
  • Toujeo
  • Tresiba
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
Companies covered
  • Wockhardt
  • Eli Lilly
  • Julphar
  • Sedico
  • Sanofi Aventis
  • Novo Nordisk
  • Exir
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032)
  4. 1.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume (2021-2032)
  5. 1.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Basal Insulin (Long-Acting Insulin) Market Dynamics
  1. 2.1 Basal Insulin (Long-Acting Insulin) Industry Trends
  2. 2.2 Basal Insulin (Long-Acting Insulin) Industry Drivers
  3. 2.3 Basal Insulin (Long-Acting Insulin) Industry Opportunities and Challenges
  4. 2.4 Basal Insulin (Long-Acting Insulin) Industry Restraints
3 Basal Insulin (Long-Acting Insulin) Market by Company
  1. 3.1 Global Basal Insulin (Long-Acting Insulin) Company Revenue Ranking in 2025
  2. 3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2021-2026)
  3. 3.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Company (2021-2026)
  4. 3.4 Global Basal Insulin (Long-Acting Insulin) Average Price by Company (2021-2026)
  5. 3.5 Global Basal Insulin (Long-Acting Insulin) Company Ranking (2024-2026)
  6. 3.6 Global Basal Insulin (Long-Acting Insulin) Company Manufacturing Base and Headquarters
  7. 3.7 Global Basal Insulin (Long-Acting Insulin) Company Product Type and Application
  8. 3.8 Global Basal Insulin (Long-Acting Insulin) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Basal Insulin (Long-Acting Insulin) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Basal Insulin (Long-Acting Insulin) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Basal Insulin (Long-Acting Insulin) Market by Type
  1. 4.1 Basal Insulin (Long-Acting Insulin) Type Introduction
  2. 4.1.1 Basaglar
  3. 4.1.2 Lantus
  4. 4.1.3 Levemir
  5. 4.1.4 Biosimilar Glargines
  6. 4.1.5 Toujeo
  7. 4.1.6 Tresiba
  8. 4.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type
  9. 4.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Basal Insulin (Long-Acting Insulin) Sales Value by Type
  13. 4.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2021-2032)
  15. 4.3.3 Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Type (2021-2032)
5 Basal Insulin (Long-Acting Insulin) Market by Application
  1. 5.1 Basal Insulin (Long-Acting Insulin) Application Introduction
  2. 5.1.1 Type 1 Diabetes
  3. 5.1.2 Type 2 Diabetes
  4. 5.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application
  5. 5.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Basal Insulin (Long-Acting Insulin) Sales Value by Application
  9. 5.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Basal Insulin (Long-Acting Insulin) Sales Value Share by Application (2021-2032)
6 Basal Insulin (Long-Acting Insulin) Regional Sales and Value Analysis
  1. 6.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2032)
  3. 6.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021-2026
  4. 6.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2027-2032)
  5. 6.3 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2027-2032)
  9. 6.5 Global Basal Insulin (Long-Acting Insulin) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032)
  12. 6.6.2 North America Basal Insulin (Long-Acting Insulin) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032)
  15. 6.7.2 Europe Basal Insulin (Long-Acting Insulin) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032)
  21. 6.9.2 South America Basal Insulin (Long-Acting Insulin) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value Share by Country, 2025 VS 2032
7 Basal Insulin (Long-Acting Insulin) Country-level Sales and Value Analysis
  1. 7.1 Global Basal Insulin (Long-Acting Insulin) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2032)
  4. 7.3.1 Global Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026)
  5. 7.3.2 Global Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032)
  6. 7.4 Global Basal Insulin (Long-Acting Insulin) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Basal Insulin (Long-Acting Insulin) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Basal Insulin (Long-Acting Insulin) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Basal Insulin (Long-Acting Insulin) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wockhardt
  2. 8.1.1 Wockhardt Company Information
  3. 8.1.2 Wockhardt Business Overview
  4. 8.1.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
  6. 8.1.5 Wockhardt Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Julphar
  14. 8.3.1 Julphar Company Information
  15. 8.3.2 Julphar Business Overview
  16. 8.3.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
  18. 8.3.5 Julphar Recent Developments
  19. 8.4 Sedico
  20. 8.4.1 Sedico Company Information
  21. 8.4.2 Sedico Business Overview
  22. 8.4.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
  24. 8.4.5 Sedico Recent Developments
  25. 8.5 Sanofi Aventis
  26. 8.5.1 Sanofi Aventis Company Information
  27. 8.5.2 Sanofi Aventis Business Overview
  28. 8.5.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
  30. 8.5.5 Sanofi Aventis Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Exir
  38. 8.7.1 Exir Company Information
  39. 8.7.2 Exir Business Overview
  40. 8.7.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
  42. 8.7.5 Exir Recent Developments
  43. 8.8 Biocon
  44. 8.8.1 Biocon Company Information
  45. 8.8.2 Biocon Business Overview
  46. 8.8.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
  48. 8.8.5 Biocon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Basal Insulin (Long-Acting Insulin) Value Chain Analysis
  2. 9.1.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Basal Insulin (Long-Acting Insulin) Sales Mode & Process
  6. 9.2 Basal Insulin (Long-Acting Insulin) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Basal Insulin (Long-Acting Insulin) Distributors
  9. 9.2.3 Basal Insulin (Long-Acting Insulin) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst